Commission Implementing Regulation (EU) 2022/489 of 25 March 2022 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances flubendiamide, L-ascorbic acid, spinetoram and spirotetramat (Text with EEA relevance)
Article 1
In force · version of Apr 17, 2022
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.